PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,350 Cr | ₹2,134 Cr | ₹1,799 Cr | ₹1,785 Cr | ₹1,575 Cr |
What is the latest Sundry Debtors ratio of PIRAMAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,350 Cr |
| Mar2024 | ₹2,134 Cr |
| Mar2023 | ₹1,799 Cr |
| Mar2022 | ₹1,785 Cr |
| Mar2021 | ₹1,575 Cr |
How is Sundry Debtors of PIRAMAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,350 Cr | 10.08 | |
| Mar2024 | ₹2,134 Cr | 18.62 | |
| Mar2023 | ₹1,799 Cr | 0.79 | |
| Mar2022 | ₹1,785 Cr | 13.36 | |
| Mar2021 | ₹1,575 Cr | - | |
Compare Sundry Debtors of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,838.8 Cr | 6.8% | 20.8% | -24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 6.8% |
20.8% |
-24.6% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses